Investors

SEC Filings

SEC Filings

Filing date	Form	Description	View
November 3, 2022	10-Q	Quarterly report which provides a continuing view of a company's financial position	0001628280-22-028242.pdf 0001628280-22-028242.rtf 0001628280-22-028242.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
May 8, 2023	10-Q	Quarterly report which provides a continuing view of a company's financial position	0001628280-23-016258.pdf 0001628280-23-016258.rtf 0001628280-23-016258.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
August 28, 2023	10-Q	Quarterly report which provides a continuing view of a company's financial position	0001628280-23-030698.pdf 0001628280-23-030698.rtf 0001628280-23-030698.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
November 8, 2023	10-Q	Quarterly report which provides a continuing view of a company's financial position	0001628280-23-037557.pdf 0001628280-23-037557.rtf 0001628280-23-037557.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
May 9, 2024	10-Q	Quarterly report which provides a continuing view of a company's financial position	0001628280-24-021945.pdf 0001628280-24-021945.rtf 0001628280-24-021945.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
August 28, 2023	10-K/A	Amendment to a previously filed 10-K	0001628280-23-030697.pdf 0001628280-23-030697.rtf 0001628280-23-030697.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
March 4, 2015	10-K	Annual report which provides a comprehensive overview of the company for the past year	0001564590-15-001260.pdf 0001564590-15-001260.rtf 0001564590-15-001260.xls EX-101.INS - XBRL INSTANCE DOCUMENT View HTML
March 14, 2016	10-K	Annual report which provides a comprehensive overview of the company for the past year	0001564590-16-014700.pdf 0001564590-16-014700.rtf 0001564590-16-014700.xls EX-101.INS - XBRL INSTANCE DOCUMENT View HTML
March 6, 2017	10-K	Annual report which provides a comprehensive overview of the company for the past year	0001564590-17-003466.pdf 0001564590-17-003466.rtf 0001564590-17-003466.xls EX-101.INS - XBRL INSTANCE DOCUMENT View HTML
March 12, 2018	10-K	Annual report which provides a comprehensive overview of the company for the past year	0001564590-18-005286.pdf 0001564590-18-005286.rtf 0001564590-18-005286.xls EX-101.INS - XBRL INSTANCE DOCUMENT View HTML

Data provided by Kaleidoscope.

Print Page

Email Page

Contact IR

Email Alerts

Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098 phone
+1 617.871.2099 fax